AI Theatre Session: Panel Discussion

AI-SC 20 - The regulatory landscape: navigating regulatory clearance, reimbursement, and liability

Lectures

1
Panel discussion

Panel discussion

45:00Catherine Mary Jones, Brisbane / AU, Sergey Morozov, Brussels / BE, Luis Marti-Bonmati, València / ES, Shahriar Islam, London / UK

5 min
Chairperson's introduction
Elmar Kotter, Freiburg Im Breisgau / Germany
45 min
Panel discussion
Shahriar Islam, London / United Kingdom
Sergey Morozov, Brussels / Belgium
Catherine Mary Jones, Brisbane / Australia
Luis Marti-Bonmati, Valencia / Spain
  1. To clarify current FDA regulatory pathways for AI/ML-based medical devices.
  2. To discuss evolving reimbursement models for AI-augmented radiology services.
  3. To address medicolegal considerations and liability distribution between radiologists, institutions, and AI vendors.
  4. To explore international regulatory harmonization efforts.
  5. To examine the role of continuous learning algorithms and post-market surveillance.
10 min
Q&A: Untangling regulation, payment and risk in AI radiology